Shalby Q1 Results: Consolidated net profit rises 37% YoY to ₹105 crore

1 min read     Updated on 13 Aug 2026, 01:31 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Shalby Limited delivered strong consolidated results for Q1FY27, with net profit jumping 37% YoY to ₹104.96 million on the back of 11.7% revenue growth. However, standalone net profit edged down 2.4% to ₹250.66 million, indicating margin pressures in the core hospital business despite higher operational income. The results were approved by the Board on August 12, 2026.

powered bylight_fuzz_icon
48153675

*this image is generated using AI for illustrative purposes only.

Shalby Limited reported a significant improvement in consolidated profitability for the first quarter of FY27, with net profit after tax rising nearly 37% year-on-year. The Ahmedabad-based healthcare provider posted consolidated earnings of ₹104.96 million for the quarter ended June 30, 2026, up from ₹76.78 million in the same period last year. This growth was supported by an 11.7% increase in total income from operations, which reached ₹3,312.24 million compared to ₹2,964.26 million in Q1FY26.

In contrast, the standalone segment saw a slight contraction in bottom-line figures. Standalone net profit after tax fell 2.4% to ₹250.66 million from ₹256.95 million in the prior year quarter, despite a 7.3% rise in operational income to ₹2,537.91 million. The divergence between standalone and consolidated performance highlights the contribution of subsidiaries or associates to the group's overall financial health during the period.

Financial Performance Overview

The Board of Directors approved the unaudited financial results at its meeting held on August 12, 2026. The results were filed with the stock exchanges pursuant to Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Metric Consolidated Q1FY27 Consolidated Q1FY26 Standalone Q1FY27 Standalone Q1FY26
Total Income (₹ mn) 3,312.24 2,964.26 2,537.91 2,365.64
Net Profit After Tax (₹ mn) 104.96 76.78 250.66 256.95
Basic EPS (₹) 0.98 0.71 2.33 2.39

Consolidated basic earnings per share (EPS) increased to ₹0.98 from ₹0.71 in the previous year quarter. Standalone basic EPS declined slightly to ₹2.33 from ₹2.39. The company’s paid-up equity share capital remained stable at ₹1,075.26 million.

What the Numbers Show

A key analytical observation from the filing is the widening gap between standalone and consolidated profits. While standalone revenue grew steadily, the consolidated net profit surged disproportionately higher than the standalone figure. In Q1FY26, consolidated PAT was approximately 30% of standalone PAT (₹76.78 mn vs ₹256.95 mn). In Q1FY27, this ratio shifted as consolidated PAT improved significantly, suggesting that non-standalone entities or other income streams contributed more heavily to the bottom line this quarter, even as the core standalone hospital operations faced margin pressure reflected in the slight dip in standalone net profit despite revenue growth.

Historical Stock Returns for Shalby

1 Day5 Days1 Month6 Months1 Year5 Years
+0.16%-4.33%-7.63%-1.05%-24.63%-18.92%

Which specific subsidiaries or associates drove the disproportionate surge in consolidated profits compared to the standalone segment?

What operational factors contributed to the margin pressure that caused standalone net profit to decline despite a 7.3% rise in operational income?

How does management plan to address the widening divergence between standalone and consolidated profitability in upcoming quarters?

Shalby Q1 Results: Net profit rises 21% YoY, EBITDA margin dips

1 min read     Updated on 12 Aug 2026, 11:33 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Shalby Hospitals delivered an 11% revenue increase to ₹3.3 billion and a 21% rise in net profit to ₹108 million in Q1. However, EBITDA margin contracted sharply to 12.55% from 14.01%, as operating profits remained flat at ₹416 million. The disparity between flat EBITDA growth and strong net profit growth suggests non-operational drivers boosted the bottom line.

powered bylight_fuzz_icon
48103403

*this image is generated using AI for illustrative purposes only.

Shalby Hospitals reported a mixed financial performance for the first quarter, with top-line growth outpaced by a contraction in operating margins. The healthcare provider saw its revenue rise 11% year-on-year to ₹3.3 billion, while net profit climbed 21% to ₹108 million. However, the expansion in profit was not fully reflected in operating metrics, as EBITDA remained nearly flat at ₹416 million compared to ₹415 million in the prior year period.

The divergence between revenue growth and EBITDA stability resulted in a notable compression of profitability ratios. The EBITDA margin fell from 14.01% in the previous year’s first quarter to 12.55% this period. This suggests that input costs or operational expenses grew faster than revenues, eroding the operating leverage typically expected from such top-line expansion.

Financial Highlights

Metric: Q1 Current Q1 Prior Year (YoY) Change
Revenue: ₹3.3 billion ₹2.96 billion +11.5%
EBITDA: ₹416 million ₹415 million +0.2%
EBITDA Margin: 12.55% 14.01% -146 bps
Net Profit: ₹108 million ₹89 million +21.3%

What the Numbers Show

The data reveals a disconnect between operational earnings and bottom-line results. While EBITDA grew marginally by just ₹1 million (0.2%), net profit surged by ₹19 million (21%). This significant gap implies that non-operating factors, such as other income or tax benefits, likely contributed disproportionately to the net profit figure, rather than core operational efficiency. Investors should note that the 146 basis point drop in EBITDA margin indicates rising cost pressures that were not passed on to customers or managed through volume efficiencies in this quarter.

Historical Stock Returns for Shalby

1 Day5 Days1 Month6 Months1 Year5 Years
+0.16%-4.33%-7.63%-1.05%-24.63%-18.92%

What specific operational cost drivers are responsible for the 146 bps compression in EBITDA margins, and can management implement pricing power to offset these input cost increases?

How sustainable is the 21% net profit growth given its reliance on non-operating factors rather than core operational efficiency, and what risks does this pose for future quarters?

Will Shalby Hospitals adjust its capital expenditure plans or expansion strategy in response to the current erosion of operating leverage?

More News on Shalby

1 Year Returns:-24.63%